Suppr超能文献

DNA合成速率作为药物毒性的指标及癌症治疗疗程安排的指导。

Rate of DNA synthesis as an indication of drug toxicity and as a guide for scheduling cancer therapy.

作者信息

Wheeler G P, Alexander J A

出版信息

Cancer Treat Rep. 1978 May;62(5):755-69.

PMID:657161
Abstract

The rates of incorporation of [C3H3]thymidine into the DNA of tissues of normal mice at various times after single doses of several drugs (adriamycin, vincristine, methotrexate, 5-fluorouracil [5-FU], melphalan, CCNU, and chlorozotocin) that have some clinical activity against cancer have been determined and are considered to be indicative of the "degree of normalcy" of the respective tissues at those times. These experiments show that there are some differences and some similarities in the effects of the agents upon the various tissues of the mouse. Each of the agents caused early inhibition of incorporation of [C3H3]thymidine followed by stimulation of such incorporation by intestinal mucosa and marrow, but the timing and the extents of inhibition and stimulation differed for the various agents. Except for CCNU, the preceding description would also apply to the effects upon liver and lungs, but the stimulation was delayed in comparison to that of intestinal mucosa and marrow. Early inhibition with little subsequent stimulation occurred in the spleen, kidneys, and heart. For all tissues, recovery was slower and less extensive after CCNU than after the other agents. The data obtained with the single agents were used for setting up experiments in which a single dose of one agent was followed after selected intervals of time with a single dose of a second agent. The combination of adriamycin plus 5-FU was less toxic when the two agents were given simultaneously than when the 5-FU was given 24-96 hours after the adriamycin, while for the combination of adriamycin plus CCNU there was less toxicity if the CCNU was administered 24 hours after the adriamycin rather than simultaneously with it. When a combination of a single dose of methotrexate and a single dose of 5-FU was administered to mice, the lethality was greater when the two agents were administered 120 hours apart than when the two agents were given simultaneously or were separated by 24 or 48 hours; this was true regardless of which agent was administered first. These results are consistent with what might be predicted upon the basis of the data obtained for the single agents in this study and of what is known about the mechanisms of action of these agents and of the effects of the agents in relation to cell and tissue kinetics. These results indicate that patterns of thymidine fixation by tissues following single doses of agents might be useful in scheduling multiple-drug therapy to minimize host toxicity.

摘要

在给予几种对癌症具有一定临床活性的药物(阿霉素、长春新碱、甲氨蝶呤、5-氟尿嘧啶[5-FU]、美法仑、环己亚硝脲和氯脲霉素)单剂量后的不同时间,测定了[C³H₃]胸腺嘧啶核苷掺入正常小鼠组织DNA中的速率,这些速率被认为可指示当时各组织的“正常程度”。这些实验表明,这些药物对小鼠不同组织的作用存在一些差异和一些相似之处。每种药物均导致[C³H₃]胸腺嘧啶核苷掺入的早期抑制,随后肠道黏膜和骨髓对其掺入有刺激作用,但不同药物的抑制和刺激的时间及程度有所不同。除环己亚硝脲外,上述描述也适用于对肝脏和肺的作用,但与肠道黏膜和骨髓相比,刺激出现延迟。脾脏、肾脏和心脏出现早期抑制且随后几乎没有刺激。对于所有组织,环己亚硝脲处理后的恢复比其他药物处理后更慢且程度更小。用单一药物获得的数据用于开展实验,即在选定的时间间隔后给予单剂量的一种药物,接着再给予单剂量的另一种药物。阿霉素加5-FU联合用药时,两种药物同时给予比阿霉素给药24 - 96小时后给予5-FU毒性更小,而对于阿霉素加环己亚硝脲的联合用药,如果环己亚硝脲在阿霉素给药24小时后而非与之同时给药,则毒性更小。当给小鼠给予单剂量甲氨蝶呤和单剂量5-FU的联合用药时,两种药物间隔120小时给药比同时给药或间隔24或48小时给药致死性更高;无论哪种药物先给药,情况均如此。这些结果与基于本研究中单一药物获得的数据以及关于这些药物的作用机制以及药物与细胞和组织动力学关系的已知情况所预测的结果一致。这些结果表明,单剂量药物处理后组织中胸腺嘧啶核苷固定模式可能有助于安排多药治疗方案以最小化宿主毒性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验